Success Metrics

Clinical Success Rate

85.7%

Based on 6 completed trials

Completion Rate

86%(6/7)

Active Trials

0(0%)

Results Posted

50%(3 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_2

57%

Ph phase_1

43%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

3(42.9%)

Phase 2Efficacy & side effects

4(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Terminated(1)

Detailed Status

Completed6

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

85.7%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (42.9%)

Phase 24 (57.1%)

Trials by Status

terminated114%

completed686%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_2

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

NCT06074562

completedphase_2

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis

NCT04627038

terminatedphase_2

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain

NCT04707157

completedphase_2

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain

NCT04874636

completedphase_1

A Study of Effect of LY3556050 on Metformin in Healthy Participants

NCT05615467

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT06074562Phase 2

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Completed

NCT04627038Phase 2

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis

Completed

NCT04707157Phase 2

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain

Terminated

NCT04874636Phase 2

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain

Completed

NCT05615467Phase 1

A Study of Effect of LY3556050 on Metformin in Healthy Participants

Completed

NCT05341102Phase 1

A Study of Single and Repeated Doses of LY3556050 in Healthy Participants

Completed

NCT04156750Phase 1

A Study of LY3556050 in Healthy Participants

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7